NasdaqGM:TRVIPharmaceuticals
Is Trevi Therapeutics (TRVI) Fully Priced On Its Russell Index Removal?
Trevi Therapeutics (TRVI) was recently removed from several Russell indexes, including the Russell 3000E and Russell Microcap families. This index reshuffle can influence index fund trading and liquidity around the stock.
See our latest analysis for Trevi Therapeutics.
Despite the index removals, Trevi Therapeutics has shown strong momentum, with a 30 day share price return of 46.29% and a year to date share price return of 64.00%. The 1 year total shareholder return of 233.05% points to very...